Skip to content
10-K/A

Annual Report

CNS Pharmaceuticals, Inc. CNSP

0001683168-25-002998

← back to feed
Filed
Apr 30, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 31, 2025 2.94M sh